The Canadian effort to prevent and control hypertension: can other countries adopt Canadian strategies?

被引:65
作者
Campbell, Norm R. C. [1 ,2 ,3 ]
Sheldon, Tobe [4 ]
机构
[1] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Med, Calgary, AB T2N 4Z6, Canada
[2] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Community Hlth Sci, Calgary, AB T2N 4Z6, Canada
[3] Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB T2N 4Z6, Canada
[4] Univ Toronto, Dept Med, Sunnybrook Hlth Sci Ctr, Div Nephrol,Sunnybrook Res Inst, Toronto, ON, Canada
关键词
clinical practice guidelines; epidemiology; high blood pressure; hypertension; public health; EDUCATION-PROGRAM RECOMMENDATIONS; BLOOD-PRESSURE; DRUG PRESCRIPTIONS; GLOBAL BURDEN; CONTROL RATES; MANAGEMENT; HEALTH; PREVALENCE; TRENDS; DIAGNOSIS;
D O I
10.1097/HCO.0b013e32833a3632
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Purpose of review To indicate the key elements of current Canadian programs to treat and control hypertension. Recent findings In the early 1990s Canada had a hypertension treatment and control rate of 13%. A Canadian strategy to prevent and control hypertension was developed and a coalition of national organizations and volunteers formed to develop increasingly extensive programs. The Canadian effort was largely based on annually updated hypertension management recommendations, an integrated and extensive hypertension knowledge translation program and an increasingly comprehensive outcomes assessment program. After the start of the annual process in 1999, there were very large increases in diagnosis and hypertension treatment coupled with dropping rates of cardiovascular disease. More recent initiatives include an extensive education program for the public and people with hypertension, a program to reduce dietary salt and a funded leadership position. The treatment and control rate increased to 66% when last assessed (2007-2009). Summary The study describes important aspects of the Canadian hypertension management programs to aid those wishing to develop similar programs. Many of the programs could be fully or partially implemented by other countries.
引用
收藏
页码:366 / 372
页数:7
相关论文
共 47 条
[1]
Stage IV Chronic Kidney Disease [J].
Abboud, Hanna ;
Henrich, William L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (01) :56-65
[2]
[Anonymous], APPR GUID RES EV AGR
[3]
Chronic diseases 3 - Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use [J].
Asaria, Perviz ;
Chisholm, Dan ;
Mathers, Colin ;
Ezzati, Majid ;
Beaglehole, Robert .
LANCET, 2007, 370 (9604) :2044-2053
[4]
BILD D, 1987, PUBLIC HEALTH REP, V102, P522
[5]
CAMPBELL N, CAN J CARDI IN PRESS
[6]
Canada Chair in hypertension prevention and control: A pilot project [J].
Campbell, Norm R. C. .
CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 (07) :557-560
[7]
Barriers and remaining questions on assessment of absolute cardiovascular risk as a starting point for interventions to reduce cardiovascular risk [J].
Campbell, Norm R. C. ;
Khan, Nadia A. ;
Grover, Steven A. .
JOURNAL OF HYPERTENSION, 2006, 24 (09) :1683-1685
[8]
Increases in Antihypertensive Prescriptions and Reductions in Cardiovascular Events in Canada [J].
Campbell, Norm R. C. ;
Brant, Rollin ;
Johansen, Helen ;
Walker, Robin L. ;
Wielgosz, Andreas ;
Onysko, Jay ;
Gao, Ru-Nie ;
Sambell, Christie ;
Phillips, Stephen ;
McAlister, Finlay A. .
HYPERTENSION, 2009, 53 (02) :128-134
[9]
The Outcomes Research Task Force and the Canadian Hypertension Education Program [J].
Campbell, Norman R. ;
Onysko, Jay .
CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 (07) :556-558
[10]
The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends [J].
Campbell, NRC ;
Tu, K ;
Brant, R ;
Duong-Hua, M ;
McAlister, FA .
HYPERTENSION, 2006, 47 (01) :22-28